MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Pattern and Presentation of Parkinson Disease in two Teaching Hospitals in Enugu, South East Nigeria

    B. Ezeala-Adikaibe (Enugu, Nigeria)

    Objective: To describe the pattern of presentation of Parkinson disease in patients attending medical out-patient clinic in Enugu South East Nigeria. Background: Parkinson Disease is…
  • 2019 International Congress

    DBS Programming In Tremor And Akinetic-Rigid Predominant Parkinson’s Disease

    Z. Guduru, D. Ginjupally, T. Ali, N. El Seblani, J. Quintero, C. van Horne (Lexington, KY, USA)

    Objective: Deep brain stimulation (DBS) targeting Globus pallidus pars interna (GPi) and subthalamic nucleus (STN) is an established surgical treatment for Parkinson’s disease (PD). Due…
  • 2019 International Congress

    Relationship between intestinal bacteria, bacterial metabolites and residual pesticides in Parkinson’s disease

    M. Hirayama, T. Hamaguchi, M. Ito, T. Ishida, M. Kuki, T. Maeda, K. Kashihara, Y. Tsuboi, K. Ohno (Hukuoka, Japan)

    Objective: We examined the relationship between intestinal bacteria, oral bacteria, bacterial metabolites, residual pesticides and clinical symptoms. Background: Intestinal environment is thought to be involved…
  • 2019 International Congress

    Applicability of modified definition of Vascular Parkinsonism in patients with Parkinsonism attending outpatient department: A tertiary care hospital-based study in south India

    S. Jaiswal (Hyderabad, India)

    Objective: This study aims to assess the applicability of modified Vascular Parkinsonism (VP) criteria in outpatient department in a tertiary care hospital in south India.…
  • 2019 International Congress

    Attitude of Parkinson Patients towards Participation in Clinical Trials and Brain or Tissue Donation for Research

    S. Khan, J. Foo, N. Chia, S. Agustin, S. Neo, T. Yaw, A. Lok, A. Ng, L. Tan (Singapore, Singapore)

    Objective: A comprehensive survey of patient preferences and attitudes towards clinical trials and tissue donation can help identify and address barriers hindering the recruitment for…
  • 2019 International Congress

    Speech and language changes in cognitive impairment subtypes in patients with Parkinson´s disease

    A. Kušnírová, Z. Košutzká, M. Hajdúk, M. Králová, M. Pápayová, M. Egryová, P. Valkovič, Z. Cséfalvay (Bratislava, Slovakia)

    Objective: The aim of our study was to compare speech (intelligibility and comprehensibility) and language (lexical-semantic aspect) abilities with cognitive profiles in patients with Parkinson´s…
  • 2019 International Congress

    Correlation Between PDQ-39 and MDS-UPDRS Scores in a Phase 3 Randomized Controlled Trial of Patients with Parkinson’s Disease

    T. Lokhandwala, A. Lee, B. Yue, A. Thach, B. Navia (Palm Harbor, FL, USA)

    Objective: To describe correlations of the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) part III scores with the 39-item Parkinson’s disease (PD) questionnaire…
  • 2019 International Congress

    Amylin deposition in the brain of Parkinson’s disease patients

    I. Martinez-Valbuena, R. Valenti-Azcarate, J. Sanchez, I. Marcilla Garcia, G. Marti Andres, MT. Tuñon-Alvarez, MR. Luquin Piudo (Pamplona, Spain)

    Objective: The objective of this study was to determine the presence of amylin deposits in the brain of subjects with synucleinopathies. Background: The link between…
  • 2019 International Congress

    Predictors of Retention for Carbidopa/Levodopa Intestinal Gel in Parkinson Disease

    A. Nagy, T. Davis, T. Hassell, P. Hedera, D. Isaacs, H. Koons, F. Phibbs, S. Afrow, J. Fang (Nashville, TN, USA)

    Objective: To identify predictors of discontinuation of levodopa/carbidopa intestinal gel therapy. Background: Although levodopa/carbidopa intestinal gel (LCIG) is an established treatment for Parkinson's disease complicated…
  • 2019 International Congress

    Parkinson’s Disease Presentation in Calabar, Nigeria

    S. Oparah, U. Williams, J. Mwankon (Calabar, Nigeria)

    Objective: To create a database and describe the presentation of Parkinson's disease patients at the sole tertiary hospital in Calabar, southern Nigeria. Background: Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 149
  • 150
  • 151
  • 152
  • 153
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley